Skip to search boxSkip to navigationSkip to main content

Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling

  • Shengmin Yan
    ,
  • Bilon Khambu
    ,
  • Xiaoyun Chen
    ,
  • ,
  • Grace Guo
    ,
  • Xiao Ming Yin(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

<p>Background & Aims: The functions of the liver and the intestine are closely tied in both physiological and pathologic conditions. The gut microbiota (GM) often cause deleterious effects during hepatic pathogenesis. Autophagy is essential for liver homeostasis, but the impact of hepatic autophagy function on liver-gut interaction remains unknown. Here we investigated the effect of hepatic autophagy deficiency (Atg5Δhep) on GM and in turn the effect of GM on the liver pathology. Methods: Fecal microbiota were analyzed by 16S sequencing. Antibiotics were used to modulate GM. Cholestyramine was used to reduce the enterohepatic bile acid (BA) level. The functional role of fibroblast growth factor 15 (FGF15) and ileal farnesoid X receptor (FXR) was examined in mice overexpressing FGF15 gene or in mice given a fibroblast growth factor receptor-4 (FGFR4) inhibitor. Results: Atg5Δhep causes liver injury and alterations of intestinal BA composition, with a lower proportion of tauro-conjugated BAs and a higher proportion of unconjugated BAs. The composition of GM is significantly changed with an increase in BA-metabolizing bacteria, leading to an increased expression of ileal FGF15 driven by FXR that has a higher affinity to unconjugated BAs. Notably, antibiotics or cholestyramine treatment decreased FGF15 expression and exacerbated liver injury. Consistently, inhibition of FGF15 signaling in the liver enhances liver injury. Conclusions: Deficiency of autophagy function in the liver can affect intestinal environment, leading to gut dysbiosis. Surprisingly, such changes provide an adaptive protection against the liver injury through the FGF15-FGFR4 signaling. Antibiotics use in the condition of liver injury may thus have unexpected adverse consequences via the gut-liver axis.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 973-997 (25 pages)

Journal (Volume, Issue Number)

CMGH (Volume 11, Issue 4)

Publication milestones

  • Published - 01/2021

Publication status

Published - 01/2021

Publication IDs

  • Scopus: 85100960146
  • PubMed: 33127558

Publication metrics

Metrics

SciVal
FWCI
3.57
SciVal
Author count
6
SciVal
Paper percentile
96
SciVal
Top percentile
5
SciVal
citations
2
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
26
Captures
23

Funding Details

Funding Supported in part by the USA National Institutes of Health (NIH) grants DK116605 (to X.-M. Yin).
FundersFunding number
NIH
-
NIDDK
R01DK116605